Literature DB >> 17347916

Molecular and clinical aspects of peroxisomal diseases.

N Shimozawa1.   

Abstract

Peroxisomal diseases, an expanding group of inborn errors of metabolism, can be classified into three categories--peroxisome biogenesis disorders (PBDs), single peroxisomal enzyme deficiencies, and contiguous gene syndrome. PBDs comprise 13 complementation groups and their responsible genes have been identified, including our newly identified group with a PEX14 defect. We have established a diagnostic system of peroxisomal diseases in Japan, and have identified 40 Japanese with PBDs, 11 patients with beta-oxidation enzyme deficiencies and more than 100 patients with adrenoleukodystrophy. Further study of and enlightenment on peroxisomal diseases is necessary to overcome these disorders.

Entities:  

Mesh:

Year:  2007        PMID: 17347916     DOI: 10.1007/s10545-007-0516-z

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.750


  11 in total

Review 1.  Peroxisome biogenesis disorders.

Authors:  Steven J Steinberg; Gabriele Dodt; Gerald V Raymond; Nancy E Braverman; Ann B Moser; Hugo W Moser
Journal:  Biochim Biophys Acta       Date:  2006-09-14

2.  Genetic basis of peroxisome-assembly mutants of humans, Chinese hamster ovary cells, and yeast: identification of a new complementation group of peroxisome-biogenesis disorders apparently lacking peroxisomal-membrane ghosts.

Authors:  N Shimozawa; Y Suzuki; Z Zhang; A Imamura; N Kondo; N Kinoshita; Y Fujiki; T Tsukamoto; T Osumi; T Imanaka; T Orii; F Beemer; P Mooijer; C Dekker; R J Wanders
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

3.  Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.

Authors:  S Ferdinandusse; P Kostopoulos; S Denis; H Rusch; H Overmars; U Dillmann; W Reith; D Haas; R J A Wanders; M Duran; M Marziniak
Journal:  Am J Hum Genet       Date:  2006-03-29       Impact factor: 11.025

Review 4.  Peroxisomal disorders: the single peroxisomal enzyme deficiencies.

Authors:  Ronald J A Wanders; Hans R Waterham
Journal:  Biochim Biophys Acta       Date:  2006-08-23

Review 5.  Molecular and neurologic findings of peroxisome biogenesis disorders.

Authors:  Nobuyuki Shimozawa; Tomoko Nagase; Yasuhiko Takemoto; Michinori Funato; Naomi Kondo; Yasuyuki Suzuki
Journal:  J Child Neurol       Date:  2005-04       Impact factor: 1.987

6.  Epidemiology of X-linked adrenoleukodystrophy in Japan.

Authors:  Yasuhiko Takemoto; Yasuyuki Suzuki; Akiko Tamakoshi; Osamu Onodera; Shoji Tsuji; Takashi Hashimoto; Nobuyuki Shimozawa; Tadao Orii; Naomi Kondo
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

7.  Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disorders.

Authors:  Deyanira Corzo; William Gibson; Kisha Johnson; Grant Mitchell; Guy LePage; Gerald F Cox; Robin Casey; Carolyn Zeiss; Heidi Tyson; Garry R Cutting; Gerald V Raymond; Kirby D Smith; Paul A Watkins; Ann B Moser; Hugo W Moser; Steven J Steinberg
Journal:  Am J Hum Genet       Date:  2002-04-29       Impact factor: 11.025

8.  A human gene responsible for Zellweger syndrome that affects peroxisome assembly.

Authors:  N Shimozawa; T Tsukamoto; Y Suzuki; T Orii; Y Shirayoshi; T Mori; Y Fujiki
Journal:  Science       Date:  1992-02-28       Impact factor: 47.728

9.  Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders.

Authors:  Yasuhiko Takemoto; Yasuyuki Suzuki; Ryoko Horibe; Nobuyuki Shimozawa; Ronald J A Wanders; Naomi Kondo
Journal:  Brain Dev       Date:  2003-10       Impact factor: 1.961

10.  Genetic heterogeneity of peroxisome biogenesis disorders among Japanese patients: evidence for a founder haplotype for the most common PEX10 gene mutation.

Authors:  Nobuyuki Shimozawa; Tomoko Nagase; Yasuhiko Takemoto; Toshihiro Ohura; Yasuyuki Suzuki; Naomi Kondo
Journal:  Am J Med Genet A       Date:  2003-07-01       Impact factor: 2.802

View more
  7 in total

1.  Identification of a novel PEX14 mutation in Zellweger syndrome.

Authors:  Sofie J Huybrechts; Paul P Van Veldhoven; Ilse Hoffman; Renate Zeevaert; Rita de Vos; Philippe Demaerel; Marijke Brams; Jaak Jaeken; Marc Fransen; David Cassiman
Journal:  BMJ Case Rep       Date:  2009-01-23

2.  A microfluidic device with fluorimetric detection for intracellular components analysis.

Authors:  Radosław Kwapiszewski; Maciej Skolimowski; Karina Ziółkowska; Elżbieta Jędrych; Michał Chudy; Artur Dybko; Zbigniew Brzózka
Journal:  Biomed Microdevices       Date:  2011-06       Impact factor: 2.838

3.  Blind sterile 2 (bs2), a hypomorphic mutation in Agps, results in cataracts and male sterility in mice.

Authors:  R Liegel; B Chang; R Dubielzig; D J Sidjanin
Journal:  Mol Genet Metab       Date:  2011-02-25       Impact factor: 4.797

4.  Drosophila carrying pex3 or pex16 mutations are models of Zellweger syndrome that reflect its symptoms associated with the absence of peroxisomes.

Authors:  Minoru Nakayama; Hiroyasu Sato; Takayuki Okuda; Nao Fujisawa; Nozomu Kono; Hiroyuki Arai; Emiko Suzuki; Masato Umeda; Hiroyuki O Ishikawa; Kenji Matsuno
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

5.  Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities.

Authors:  Xiao-Ming Wang; Wing Yan Yik; Peilin Zhang; Wange Lu; Ning Huang; Bo Ram Kim; Darryl Shibata; Madison Zitting; Robert H Chow; Ann B Moser; Steven J Steinberg; Joseph G Hacia
Journal:  Stem Cell Res Ther       Date:  2015-08-29       Impact factor: 6.832

6.  Serum very long-chain fatty acids (VLCFA) levels as predictive biomarkers of diseases severity and probability of survival in peroxisomal disorders.

Authors:  Teresa Joanna Stradomska; Małgorzata Syczewska; Ewa Jamroz; Agata Pleskaczyńska; Piotr Kruczek; Elżbieta Ciara; Anna Tylki-Szymanska
Journal:  PLoS One       Date:  2020-09-18       Impact factor: 3.240

7.  Metabolic causes of epileptic encephalopathy.

Authors:  Joe Yuezhou Yu; Phillip L Pearl
Journal:  Epilepsy Res Treat       Date:  2013-05-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.